Applied Molecular Transport Announces FDA Orphan Drug Designation Granted to AMT-101 for Treatment of Pouchitis

Applied Molecular Transport, Inc. announced that the US FDA has granted Orphan Drug Designation for AMT-101 in patients with pouchitis, an indication with significant unmet medical needs and no current FDA-approved products.
[Applied Molecular Transport, Inc.]
Press Release

Stay up-to-date with your field!

Subscribe for free weekly science newsletters.

Related News